Is Diamondback Energy a Good Stock to Buy?
Diamondback Energy (FANG) is a lesser-known diamond in the rough…
Buy
51
GNTA Quote, Financials, Valuation and Earnings
Last price:
$3.80
Seasonality move
:
-4.4%
Day range:
$3.93 - $4.21
52-week range:
$2.20 - $7.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.99x
Volume:
2.3K
Avg. volume:
34.3K
1-year change:
-0.06%
Market cap:
$71.9M
Revenue:
--
EPS (TTM):
-$0.53
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Genenta Science SPA has 485.55% upside to fair value with a price target of -- per share.
GNTA vs. S&P 500
-
Over the past 5 trading days, Genenta Science SPA has overperformed the S&P 500 by 1.38% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Genenta Science SPA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genenta Science SPA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Genenta Science SPA reported revenues of --.
Earnings Growth
-
Genenta Science SPA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Genenta Science SPA reported earnings per share of --.
Enterprise value:
53.8M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-8.78x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-27 | 2024-03-27 | 2024-03-27 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $14.4M | $39.1M | $26.6M | $19.9M | |
| Total Assets | -- | $15.8M | $40M | $29M | $20.4M | |
| Current Liabilities | -- | $2M | $1.3M | $1.9M | $2.1M | |
| Total Liabilities | -- | $2M | $1.3M | $2.1M | $2.4M | |
| Total Equity | -- | $13.8M | $38.6M | $27M | $18M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-27 | 2024-03-27 | 2024-03-27 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
GNTA
Sector
Market Cap
$71.9M
$39.2M
Price % of 52-Week High
53.98%
45.99%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
-0.06%
-38.63%
Beta (5-Year)
--
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.92
200-day SMA
Sell
Level
$4.29
Bollinger Bands (100)
Sell
Level
3.92 - 5.08
Chaikin Money Flow
Sell
Level
-557.2K
20-day SMA
Buy
Level
$3.90
Relative Strength Index (RSI14)
Sell
Level
49.68
ADX Line
Buy
Level
29.87
Williams %R
Neutral
Level
-58.75
50-day SMA
Sell
Level
$3.98
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
1.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
Stock Forecast FAQ
In the current month, GNTA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GNTA average analyst price target in the past 3 months is --.
-
Where Will Genenta Science SPA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genenta Science SPA share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Genenta Science SPA?
Analysts are divided on their view about Genenta Science SPA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genenta Science SPA is a Sell and believe this share price will drop from its current level to --.
-
What Is Genenta Science SPA's Price Target?
The price target for Genenta Science SPA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GNTA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genenta Science SPA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GNTA?
You can purchase shares of Genenta Science SPA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genenta Science SPA shares.
-
What Is The Genenta Science SPA Share Price Today?
Genenta Science SPA was last trading at $3.80 per share. This represents the most recent stock quote for Genenta Science SPA. Yesterday, Genenta Science SPA closed at $3.93 per share.
-
How To Buy Genenta Science SPA Stock Online?
In order to purchase Genenta Science SPA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
29
UNF alert for Mar 26
UniFirst [UNF] is up 0.24% over the past day.
Sell
30
KEQU alert for Mar 26
Kewaunee Scientific [KEQU] is down 1.45% over the past day.
Buy
82
EPAC alert for Mar 26
Enerpac Tool Group [EPAC] is down 3.19% over the past day.
